Background: Propofol is being increasingly used a公 a intravenous anesthetic, but has no remarkable analgesic effect. Previous reports demonstrated that using of propofol with opioids had synergic effects, and decreased requiring dose of propof...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A106086922
2006
Korean
학술저널
120-125(6쪽)
0
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
Background: Propofol is being increasingly used a公 a intravenous anesthetic, but has no remarkable analgesic effect. Previous reports demonstrated that using of propofol with opioids had synergic effects, and decreased requiring dose of propof...
Background: Propofol is being increasingly used a公 a intravenous anesthetic, but has no remarkable analgesic effect.
Previous reports demonstrated that using of propofol with opioids had synergic effects, and decreased requiring dose of propofol. The purpose of this study was Co examine the clinical usefulness of propofo卜fentanyl intravenous anesthesia. Methods: Sixty patients of ASA status I or II undergoing breast mass excision were studied. Intravenous anesthesia was induced with fentanyl (2 ug/kg) and bolus dose of propofol (2 mg/kg) and maintained with continuous infusion of propofol (6-10 mg/kg八irk We measured loading, maintenance and total doses of propofol,changes of blood pressure, anesthesia time,and also observed the incidences of side effects of propofol anesthesia. Results: The bolus dose of propofol was administered within average injection time of 61.2 seconds. The systolic and diastolic pressure were significantly decreased after bolus injection of propofol (p<0.05). The administered total dose of propofol was 292.4 ±77.9 mg during average anesthesia time of 27,3 minutes. The incidences of injection pain, apnea and dizziness were 46,7%,38.3% and 25% respectively. Conclusion: We concluded that the propofol-fentanyl intravenous anesthesia using infusion pump was clinically useful and safe method for short time operation.
악성 종양환자의 혈청,흉막참출액 및 뇨의 Insulin-like growth factor-I, 2 의 발현
전립선 비대증 환자에서 Alfuzosin, Doxazosin 단독요법 및 Finasteride를 포함한 병합요법의 효과비교
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2027 | 평가예정 | 재인증평가 신청대상 (재인증) | |
2021-01-01 | 평가 | 등재학술지 유지 (재인증) | |
2018-01-01 | 평가 | 등재학술지 선정 (계속평가) | |
2017-01-01 | 평가 | 등재후보학술지 유지 (계속평가) | |
2015-01-01 | 평가 | 등재후보학술지 선정 (신규평가) |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0.02 | 0.02 | 0.03 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.04 | 0.04 | 0.21 | 0 |